The Japan-based pharmaceutical company Kyowa Kirin has entered into a defin...
AstraZeneca has announced positive results from the T2NOW Phase III trial for p...
The European Medicines Agency (EMA) has provided a positive opinion for Callidi...
The US Food and Drug Administration (FDA) has granted Inhibikase Therapeutics’ ...
Advanz Pharma has signed an agreement to licence Dimerix’s drug candidate DMX-2...
US-Ireland speciality pharmaceutical company Shorla Oncology has received $35m ...
The UK national scanning programme, National PET Imaging Platform (NPIP), has b...
The US Food and Drug Administration (FDA) has issued a draft guidance to aid sp...
Antibody-drug conjugates (ADCs) saw a 400% growth in total licensing agreement ...
It's the end of an era for a once-critical pandemic document: The ubiquitous whi...
Some analysts are questioning whether Amgen was fully forthcoming about a pricey...
A bill would address a Catch-22 in some pregnancies: use prescription medication...
Nasal esketamine spray is more effective than an extended-release antipsychotic,...
One of the top health care committees in the Senate is assembling ideas for bipa...
The lawsuit filed by the Center for Science in the Public alleges that EpicGenet...
The FDA approved a new surgical device for patients with severe vascular disease...